Crescent City Health Care Inc is categorized under Family Practice Doctors in New Orleans, LA and active since 2001.
Crescent City Health Care Inc was established in 2001, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Timothy Goux at the company’s single location by writing to 3034 Gentilly Boulevard, New Orleans, Louisiana LA 70122 or by phoning (504) 895-7755. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Crescent City Health Care Inc |
| Contact Person: | Timothy Goux |
| Address: | 3034 Gentilly Boulevard, New Orleans, Louisiana 70122 |
| Phone Number: | (504) 895-7755 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Crescent City Health Care Inc was started in 2001 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Timothy Goux for inquiries that concern Crescent City Health Care Inc by calling the company number (504) 895-7755, as your correspondence is most welcome. Additionally, the physical location of the single location of Crescent City Health Care Inc can be found at the coordinates 29.997531,-90.060915 as well as the street address 3034 Gentilly Boulevard in New Orleans, Louisiana 70122.
For its online presence, you may visit Crescent City Health Care Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.